Global and China Companion Animal Pharmaceutical Market Size, Status and Forecast 2021-2027

Publisher Name :
Date: 18-Nov-2021
No. of pages: 106
Inquire Before Buying

Global Companion Animal Pharmaceutical Scope and Market Size

Companion Animal Pharmaceutical market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Companion Animal Pharmaceutical market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Indication and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Indication

- Infectious Diseases

- Dermatologic Diseases

- Pain

- Orthopedic Diseases

- Behavioral Diseases

- Other Indications

Segment by Application

- Dogs

- Cats

- Other

By Region

- North America

- - United States

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- - Nordic

- - Rest of Europe

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - Southeast Asia

- - India

- - Australia

- - Rest of Asia

- Latin America

- - Mexico

- - Brazil

- - Rest of Latin America

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

- - Rest of MEA

By Company

- Zoetis

- Boehringer Ingelheim

- Merck Animal Health

- Elanco Animal Health

- Bayer Animal Health

- Virbac

- Dechra Veterinary Products

- Ceva

- Vetoquinol

- Meiji

- Ouro Fino Saude

- Parnell

Global and China Companion Animal Pharmaceutical Market Size, Status and Forecast 2021-2027

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Companion Animal Pharmaceutical Market Size Growth Rate by Indication: 2016 VS 2021 VS 2027
1.2.2 Infectious Diseases
1.2.3 Dermatologic Diseases
1.2.4 Pain
1.2.5 Orthopedic Diseases
1.2.6 Behavioral Diseases
1.2.7 Other Indications
1.3 Market by Application
1.3.1 Global Companion Animal Pharmaceutical Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Dogs
1.3.3 Cats
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Companion Animal Pharmaceutical Market Perspective (2016-2027)
2.2 Companion Animal Pharmaceutical Growth Trends by Regions
2.2.1 Companion Animal Pharmaceutical Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Companion Animal Pharmaceutical Historic Market Share by Regions (2016-2021)
2.2.3 Companion Animal Pharmaceutical Forecasted Market Size by Regions (2022-2027)
2.3 Companion Animal Pharmaceutical Industry Dynamic
2.3.1 Companion Animal Pharmaceutical Market Trends
2.3.2 Companion Animal Pharmaceutical Market Drivers
2.3.3 Companion Animal Pharmaceutical Market Challenges
2.3.4 Companion Animal Pharmaceutical Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Companion Animal Pharmaceutical Players by Revenue
3.1.1 Global Top Companion Animal Pharmaceutical Players by Revenue (2016-2021)
3.1.2 Global Companion Animal Pharmaceutical Revenue Market Share by Players (2016-2021)
3.2 Global Companion Animal Pharmaceutical Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Companion Animal Pharmaceutical Revenue
3.4 Global Companion Animal Pharmaceutical Market Concentration Ratio
3.4.1 Global Companion Animal Pharmaceutical Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Companion Animal Pharmaceutical Revenue in 2020
3.5 Companion Animal Pharmaceutical Key Players Head office and Area Served
3.6 Key Players Companion Animal Pharmaceutical Product Solution and Service
3.7 Date of Enter into Companion Animal Pharmaceutical Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Companion Animal Pharmaceutical Breakdown Data by Indication
4.1 Global Companion Animal Pharmaceutical Historic Market Size by Indication (2016-2021)
4.2 Global Companion Animal Pharmaceutical Forecasted Market Size by Indication (2022-2027)
5 Companion Animal Pharmaceutical Breakdown Data by Application
5.1 Global Companion Animal Pharmaceutical Historic Market Size by Application (2016-2021)
5.2 Global Companion Animal Pharmaceutical Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Companion Animal Pharmaceutical Market Size (2016-2027)
6.2 North America Companion Animal Pharmaceutical Market Size by Indication
6.2.1 North America Companion Animal Pharmaceutical Market Size by Indication (2016-2021)
6.2.2 North America Companion Animal Pharmaceutical Market Size by Indication (2022-2027)
6.2.3 North America Companion Animal Pharmaceutical Market Size by Indication (2016-2027)
6.3 North America Companion Animal Pharmaceutical Market Size by Application
6.3.1 North America Companion Animal Pharmaceutical Market Size by Application (2016-2021)
6.3.2 North America Companion Animal Pharmaceutical Market Size by Application (2022-2027)
6.3.3 North America Companion Animal Pharmaceutical Market Size by Application (2016-2027)
6.4 North America Companion Animal Pharmaceutical Market Size by Country
6.4.1 North America Companion Animal Pharmaceutical Market Size by Country (2016-2021)
6.4.2 North America Companion Animal Pharmaceutical Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Companion Animal Pharmaceutical Market Size (2016-2027)
7.2 Europe Companion Animal Pharmaceutical Market Size by Indication
7.2.1 Europe Companion Animal Pharmaceutical Market Size by Indication (2016-2021)
7.2.2 Europe Companion Animal Pharmaceutical Market Size by Indication (2022-2027)
7.2.3 Europe Companion Animal Pharmaceutical Market Size by Indication (2016-2027)
7.3 Europe Companion Animal Pharmaceutical Market Size by Application
7.3.1 Europe Companion Animal Pharmaceutical Market Size by Application (2016-2021)
7.3.2 Europe Companion Animal Pharmaceutical Market Size by Application (2022-2027)
7.3.3 Europe Companion Animal Pharmaceutical Market Size by Application (2016-2027)
7.4 Europe Companion Animal Pharmaceutical Market Size by Country
7.4.1 Europe Companion Animal Pharmaceutical Market Size by Country (2016-2021)
7.4.2 Europe Companion Animal Pharmaceutical Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Companion Animal Pharmaceutical Market Size (2016-2027)
8.2 Asia-Pacific Companion Animal Pharmaceutical Market Size by Indication
8.2.1 Asia-Pacific Companion Animal Pharmaceutical Market Size by Indication (2016-2021)
8.2.2 Asia-Pacific Companion Animal Pharmaceutical Market Size by Indication (2022-2027)
8.2.3 Asia-Pacific Companion Animal Pharmaceutical Market Size by Indication (2016-2027)
8.3 Asia-Pacific Companion Animal Pharmaceutical Market Size by Application
8.3.1 Asia-Pacific Companion Animal Pharmaceutical Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Companion Animal Pharmaceutical Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Companion Animal Pharmaceutical Market Size by Application (2016-2027)
8.4 Asia-Pacific Companion Animal Pharmaceutical Market Size by Region
8.4.1 Asia-Pacific Companion Animal Pharmaceutical Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Companion Animal Pharmaceutical Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Companion Animal Pharmaceutical Market Size (2016-2027)
9.2 Latin America Companion Animal Pharmaceutical Market Size by Indication
9.2.1 Latin America Companion Animal Pharmaceutical Market Size by Indication (2016-2021)
9.2.2 Latin America Companion Animal Pharmaceutical Market Size by Indication (2022-2027)
9.2.3 Latin America Companion Animal Pharmaceutical Market Size by Indication (2016-2027)
9.3 Latin America Companion Animal Pharmaceutical Market Size by Application
9.3.1 Latin America Companion Animal Pharmaceutical Market Size by Application (2016-2021)
9.3.2 Latin America Companion Animal Pharmaceutical Market Size by Application (2022-2027)
9.3.3 Latin America Companion Animal Pharmaceutical Market Size by Application (2016-2027)
9.4 Latin America Companion Animal Pharmaceutical Market Size by Country
9.4.1 Latin America Companion Animal Pharmaceutical Market Size by Country (2016-2021)
9.4.2 Latin America Companion Animal Pharmaceutical Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Companion Animal Pharmaceutical Market Size (2016-2027)
10.2 Middle East & Africa Companion Animal Pharmaceutical Market Size by Indication
10.2.1 Middle East & Africa Companion Animal Pharmaceutical Market Size by Indication (2016-2021)
10.2.2 Middle East & Africa Companion Animal Pharmaceutical Market Size by Indication (2022-2027)
10.2.3 Middle East & Africa Companion Animal Pharmaceutical Market Size by Indication (2016-2027)
10.3 Middle East & Africa Companion Animal Pharmaceutical Market Size by Application
10.3.1 Middle East & Africa Companion Animal Pharmaceutical Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Companion Animal Pharmaceutical Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Companion Animal Pharmaceutical Market Size by Application (2016-2027)
10.4 Middle East & Africa Companion Animal Pharmaceutical Market Size by Country
10.4.1 Middle East & Africa Companion Animal Pharmaceutical Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Companion Animal Pharmaceutical Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Zoetis
11.1.1 Zoetis Company Details
11.1.2 Zoetis Business Overview
11.1.3 Zoetis Companion Animal Pharmaceutical Introduction
11.1.4 Zoetis Revenue in Companion Animal Pharmaceutical Business (2016-2021)
11.1.5 Zoetis Recent Development
11.2 Boehringer Ingelheim
11.2.1 Boehringer Ingelheim Company Details
11.2.2 Boehringer Ingelheim Business Overview
11.2.3 Boehringer Ingelheim Companion Animal Pharmaceutical Introduction
11.2.4 Boehringer Ingelheim Revenue in Companion Animal Pharmaceutical Business (2016-2021)
11.2.5 Boehringer Ingelheim Recent Development
11.3 Merck Animal Health
11.3.1 Merck Animal Health Company Details
11.3.2 Merck Animal Health Business Overview
11.3.3 Merck Animal Health Companion Animal Pharmaceutical Introduction
11.3.4 Merck Animal Health Revenue in Companion Animal Pharmaceutical Business (2016-2021)
11.3.5 Merck Animal Health Recent Development
11.4 Elanco Animal Health
11.4.1 Elanco Animal Health Company Details
11.4.2 Elanco Animal Health Business Overview
11.4.3 Elanco Animal Health Companion Animal Pharmaceutical Introduction
11.4.4 Elanco Animal Health Revenue in Companion Animal Pharmaceutical Business (2016-2021)
11.4.5 Elanco Animal Health Recent Development
11.5 Bayer Animal Health
11.5.1 Bayer Animal Health Company Details
11.5.2 Bayer Animal Health Business Overview
11.5.3 Bayer Animal Health Companion Animal Pharmaceutical Introduction
11.5.4 Bayer Animal Health Revenue in Companion Animal Pharmaceutical Business (2016-2021)
11.5.5 Bayer Animal Health Recent Development
11.6 Virbac
11.6.1 Virbac Company Details
11.6.2 Virbac Business Overview
11.6.3 Virbac Companion Animal Pharmaceutical Introduction
11.6.4 Virbac Revenue in Companion Animal Pharmaceutical Business (2016-2021)
11.6.5 Virbac Recent Development
11.7 Dechra Veterinary Products
11.7.1 Dechra Veterinary Products Company Details
11.7.2 Dechra Veterinary Products Business Overview
11.7.3 Dechra Veterinary Products Companion Animal Pharmaceutical Introduction
11.7.4 Dechra Veterinary Products Revenue in Companion Animal Pharmaceutical Business (2016-2021)
11.7.5 Dechra Veterinary Products Recent Development
11.8 Ceva
11.8.1 Ceva Company Details
11.8.2 Ceva Business Overview
11.8.3 Ceva Companion Animal Pharmaceutical Introduction
11.8.4 Ceva Revenue in Companion Animal Pharmaceutical Business (2016-2021)
11.8.5 Ceva Recent Development
11.9 Vetoquinol
11.9.1 Vetoquinol Company Details
11.9.2 Vetoquinol Business Overview
11.9.3 Vetoquinol Companion Animal Pharmaceutical Introduction
11.9.4 Vetoquinol Revenue in Companion Animal Pharmaceutical Business (2016-2021)
11.9.5 Vetoquinol Recent Development
11.10 Meiji
11.10.1 Meiji Company Details
11.10.2 Meiji Business Overview
11.10.3 Meiji Companion Animal Pharmaceutical Introduction
11.10.4 Meiji Revenue in Companion Animal Pharmaceutical Business (2016-2021)
11.10.5 Meiji Recent Development
11.11 Ouro Fino Saude
11.11.1 Ouro Fino Saude Company Details
11.11.2 Ouro Fino Saude Business Overview
11.11.3 Ouro Fino Saude Companion Animal Pharmaceutical Introduction
11.11.4 Ouro Fino Saude Revenue in Companion Animal Pharmaceutical Business (2016-2021)
11.11.5 Ouro Fino Saude Recent Development
11.12 Parnell
11.12.1 Parnell Company Details
11.12.2 Parnell Business Overview
11.12.3 Parnell Companion Animal Pharmaceutical Introduction
11.12.4 Parnell Revenue in Companion Animal Pharmaceutical Business (2016-2021)
11.12.5 Parnell Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Companion Animal Pharmaceutical Market Size Growth Rate by Indication (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Infectious Diseases
Table 3. Key Players of Dermatologic Diseases
Table 4. Key Players of Pain
Table 5. Key Players of Orthopedic Diseases
Table 6. Key Players of Behavioral Diseases
Table 7. Key Players of Other Indications
Table 8. Global Companion Animal Pharmaceutical Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Companion Animal Pharmaceutical Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 10. Global Companion Animal Pharmaceutical Market Size by Regions (2016-2021) & (US$ Million)
Table 11. Global Companion Animal Pharmaceutical Market Share by Regions (2016-2021)
Table 12. Global Companion Animal Pharmaceutical Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 13. Global Companion Animal Pharmaceutical Market Share by Regions (2022-2027)
Table 14. Companion Animal Pharmaceutical Market Trends
Table 15. Companion Animal Pharmaceutical Market Drivers
Table 16. Companion Animal Pharmaceutical Market Challenges
Table 17. Companion Animal Pharmaceutical Market Restraints
Table 18. Global Companion Animal Pharmaceutical Revenue by Players (2016-2021) & (US$ Million)
Table 19. Global Companion Animal Pharmaceutical Market Share by Players (2016-2021)
Table 20. Global Top Companion Animal Pharmaceutical Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Companion Animal Pharmaceutical as of 2020)
Table 21. Ranking of Global Top Companion Animal Pharmaceutical Companies by Revenue (US$ Million) in 2020
Table 22. Global 5 Largest Players Market Share by Companion Animal Pharmaceutical Revenue (CR5 and HHI) & (2016-2021)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Companion Animal Pharmaceutical Product Solution and Service
Table 25. Date of Enter into Companion Animal Pharmaceutical Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Companion Animal Pharmaceutical Market Size by Indication (2016-2021) (US$ Million)
Table 28. Global Companion Animal Pharmaceutical Revenue Market Share by Indication (2016-2021)
Table 29. Global Companion Animal Pharmaceutical Forecasted Market Size by Indication (2022-2027) (US$ Million)
Table 30. Global Companion Animal Pharmaceutical Revenue Market Share by Indication (2022-2027) & (US$ Million)
Table 31. Global Companion Animal Pharmaceutical Market Size Share by Application (2016-2021) & (US$ Million)
Table 32. Global Companion Animal Pharmaceutical Revenue Market Share by Application (2016-2021)
Table 33. Global Companion Animal Pharmaceutical Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 34. Global Companion Animal Pharmaceutical Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 35. North America Companion Animal Pharmaceutical Market Size by Indication (2016-2021) (US$ Million)
Table 36. North America Companion Animal Pharmaceutical Market Size by Indication (2022-2027) & (US$ Million)
Table 37. North America Companion Animal Pharmaceutical Market Size by Application (2016-2021) (US$ Million)
Table 38. North America Companion Animal Pharmaceutical Market Size by Application (2022-2027) & (US$ Million)
Table 39. North America Companion Animal Pharmaceutical Market Size by Country (2016-2021) & (US$ Million)
Table 40. North America Companion Animal Pharmaceutical Market Size by Country (2022-2027) & (US$ Million)
Table 41. Europe Companion Animal Pharmaceutical Market Size by Indication (2016-2021) (US$ Million)
Table 42. Europe Companion Animal Pharmaceutical Market Size by Indication (2022-2027) & (US$ Million)
Table 43. Europe Companion Animal Pharmaceutical Market Size by Application (2016-2021) (US$ Million)
Table 44. Europe Companion Animal Pharmaceutical Market Size by Application (2022-2027) & (US$ Million)
Table 45. Europe Companion Animal Pharmaceutical Market Size by Country (2016-2021) & (US$ Million)
Table 46. Europe Companion Animal Pharmaceutical Market Size by Country (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Companion Animal Pharmaceutical Market Size by Indication (2016-2021) (US$ Million)
Table 48. Asia-Pacific Companion Animal Pharmaceutical Market Size by Indication (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Companion Animal Pharmaceutical Market Size by Application (2016-2021) (US$ Million)
Table 50. Asia-Pacific Companion Animal Pharmaceutical Market Size by Application (2022-2027) & (US$ Million)
Table 51. Asia-Pacific Companion Animal Pharmaceutical Market Size by Region (2016-2021) & (US$ Million)
Table 52. Asia-Pacific Companion Animal Pharmaceutical Market Size by Region (2022-2027) & (US$ Million)
Table 53. Latin America Companion Animal Pharmaceutical Market Size by Indication (2016-2021) (US$ Million)
Table 54. Latin America Companion Animal Pharmaceutical Market Size by Indication (2022-2027) & (US$ Million)
Table 55. Latin America Companion Animal Pharmaceutical Market Size by Application (2016-2021) (US$ Million)
Table 56. Latin America Companion Animal Pharmaceutical Market Size by Application (2022-2027) & (US$ Million)
Table 57. Latin America Companion Animal Pharmaceutical Market Size by Country (2016-2021) & (US$ Million)
Table 58. Latin America Companion Animal Pharmaceutical Market Size by Country (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Companion Animal Pharmaceutical Market Size by Indication (2016-2021) (US$ Million)
Table 60. Middle East & Africa Companion Animal Pharmaceutical Market Size by Indication (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Companion Animal Pharmaceutical Market Size by Application (2016-2021) (US$ Million)
Table 62. Middle East & Africa Companion Animal Pharmaceutical Market Size by Application (2022-2027) & (US$ Million)
Table 63. Middle East & Africa Companion Animal Pharmaceutical Market Size by Country (2016-2021) & (US$ Million)
Table 64. Middle East & Africa Companion Animal Pharmaceutical Market Size by Country (2022-2027) & (US$ Million)
Table 65. Zoetis Company Details
Table 66. Zoetis Business Overview
Table 67. Zoetis Companion Animal Pharmaceutical Product
Table 68. Zoetis Revenue in Companion Animal Pharmaceutical Business (2016-2021) & (US$ Million)
Table 69. Zoetis Recent Development
Table 70. Boehringer Ingelheim Company Details
Table 71. Boehringer Ingelheim Business Overview
Table 72. Boehringer Ingelheim Companion Animal Pharmaceutical Product
Table 73. Boehringer Ingelheim Revenue in Companion Animal Pharmaceutical Business (2016-2021) & (US$ Million)
Table 74. Boehringer Ingelheim Recent Development
Table 75. Merck Animal Health Company Details
Table 76. Merck Animal Health Business Overview
Table 77. Merck Animal Health Companion Animal Pharmaceutical Product
Table 78. Merck Animal Health Revenue in Companion Animal Pharmaceutical Business (2016-2021) & (US$ Million)
Table 79. Merck Animal Health Recent Development
Table 80. Elanco Animal Health Company Details
Table 81. Elanco Animal Health Business Overview
Table 82. Elanco Animal Health Companion Animal Pharmaceutical Product
Table 83. Elanco Animal Health Revenue in Companion Animal Pharmaceutical Business (2016-2021) & (US$ Million)
Table 84. Elanco Animal Health Recent Development
Table 85. Bayer Animal Health Company Details
Table 86. Bayer Animal Health Business Overview
Table 87. Bayer Animal Health Companion Animal Pharmaceutical Product
Table 88. Bayer Animal Health Revenue in Companion Animal Pharmaceutical Business (2016-2021) & (US$ Million)
Table 89. Bayer Animal Health Recent Development
Table 90. Virbac Company Details
Table 91. Virbac Business Overview
Table 92. Virbac Companion Animal Pharmaceutical Product
Table 93. Virbac Revenue in Companion Animal Pharmaceutical Business (2016-2021) & (US$ Million)
Table 94. Virbac Recent Development
Table 95. Dechra Veterinary Products Company Details
Table 96. Dechra Veterinary Products Business Overview
Table 97. Dechra Veterinary Products Companion Animal Pharmaceutical Product
Table 98. Dechra Veterinary Products Revenue in Companion Animal Pharmaceutical Business (2016-2021) & (US$ Million)
Table 99. Dechra Veterinary Products Recent Development
Table 100. Ceva Company Details
Table 101. Ceva Business Overview
Table 102. Ceva Revenue in Companion Animal Pharmaceutical Business (2016-2021) & (US$ Million)
Table 103. Ceva Recent Development
Table 104. Vetoquinol Company Details
Table 105. Vetoquinol Business Overview
Table 106. Vetoquinol Companion Animal Pharmaceutical Product
Table 107. Vetoquinol Revenue in Companion Animal Pharmaceutical Business (2016-2021) & (US$ Million)
Table 108. Vetoquinol Recent Development
Table 109. Meiji Company Details
Table 110. Meiji Business Overview
Table 111. Meiji Companion Animal Pharmaceutical Product
Table 112. Meiji Revenue in Companion Animal Pharmaceutical Business (2016-2021) & (US$ Million)
Table 113. Meiji Recent Development
Table 114. Ouro Fino Saude Company Details
Table 115. Ouro Fino Saude Business Overview
Table 116. Ouro Fino Saude Companion Animal Pharmaceutical Product
Table 117. Ouro Fino Saude Revenue in Companion Animal Pharmaceutical Business (2016-2021) & (US$ Million)
Table 118. Ouro Fino Saude Recent Development
Table 119. Parnell Company Details
Table 120. Parnell Business Overview
Table 121. Parnell Companion Animal Pharmaceutical Product
Table 122. Parnell Revenue in Companion Animal Pharmaceutical Business (2016-2021) & (US$ Million)
Table 123. Parnell Recent Development
Table 124. Research Programs/Design for This Report
Table 125. Key Data Information from Secondary Sources
Table 126. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Companion Animal Pharmaceutical Market Share by Indication: 2020 VS 2027
Figure 2. Infectious Diseases Features
Figure 3. Dermatologic Diseases Features
Figure 4. Pain Features
Figure 5. Orthopedic Diseases Features
Figure 6. Behavioral Diseases Features
Figure 7. Other Indications Features
Figure 8. Global Companion Animal Pharmaceutical Market Share by Application: 2020 VS 2027
Figure 9. Dogs Case Studies
Figure 10. Cats Case Studies
Figure 11. Other Case Studies
Figure 12. Companion Animal Pharmaceutical Report Years Considered
Figure 13. Global Companion Animal Pharmaceutical Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 14. Global Companion Animal Pharmaceutical Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 15. Global Companion Animal Pharmaceutical Market Share by Regions: 2020 VS 2027
Figure 16. Global Companion Animal Pharmaceutical Market Share by Regions (2022-2027)
Figure 17. Global Companion Animal Pharmaceutical Market Share by Players in 2020
Figure 18. Global Top Companion Animal Pharmaceutical Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Companion Animal Pharmaceutical as of 2020
Figure 19. The Top 10 and 5 Players Market Share by Companion Animal Pharmaceutical Revenue in 2020
Figure 20. Global Companion Animal Pharmaceutical Revenue Market Share by Indication (2016-2021)
Figure 21. Global Companion Animal Pharmaceutical Revenue Market Share by Indication (2022-2027)
Figure 22. North America Companion Animal Pharmaceutical Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. North America Companion Animal Pharmaceutical Market Share by Indication (2016-2027)
Figure 24. North America Companion Animal Pharmaceutical Market Share by Application (2016-2027)
Figure 25. North America Companion Animal Pharmaceutical Market Share by Country (2016-2027)
Figure 26. United States Companion Animal Pharmaceutical Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Canada Companion Animal Pharmaceutical Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Companion Animal Pharmaceutical Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Europe Companion Animal Pharmaceutical Market Share by Indication (2016-2027)
Figure 30. Europe Companion Animal Pharmaceutical Market Share by Application (2016-2027)
Figure 31. Europe Companion Animal Pharmaceutical Market Share by Country (2016-2027)
Figure 32. Germany Companion Animal Pharmaceutical Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. France Companion Animal Pharmaceutical Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. U.K. Companion Animal Pharmaceutical Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Italy Companion Animal Pharmaceutical Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Russia Companion Animal Pharmaceutical Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Nordic Companion Animal Pharmaceutical Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Companion Animal Pharmaceutical Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Asia-Pacific Companion Animal Pharmaceutical Market Share by Indication (2016-2027)
Figure 40. Asia-Pacific Companion Animal Pharmaceutical Market Share by Application (2016-2027)
Figure 41. Asia-Pacific Companion Animal Pharmaceutical Market Share by Region (2016-2027)
Figure 42. China Companion Animal Pharmaceutical Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Japan Companion Animal Pharmaceutical Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. South Korea Companion Animal Pharmaceutical Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Southeast Asia Companion Animal Pharmaceutical Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. India Companion Animal Pharmaceutical Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Australia Companion Animal Pharmaceutical Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Companion Animal Pharmaceutical Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Latin America Companion Animal Pharmaceutical Market Share by Indication (2016-2027)
Figure 50. Latin America Companion Animal Pharmaceutical Market Share by Application (2016-2027)
Figure 51. Latin America Companion Animal Pharmaceutical Market Share by Country (2016-2027)
Figure 52. Mexico Companion Animal Pharmaceutical Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Brazil Companion Animal Pharmaceutical Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Companion Animal Pharmaceutical Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Middle East & Africa Companion Animal Pharmaceutical Market Share by Indication (2016-2027)
Figure 56. Middle East & Africa Companion Animal Pharmaceutical Market Share by Application (2016-2027)
Figure 57. Middle East & Africa Companion Animal Pharmaceutical Market Share by Country (2016-2027)
Figure 58. Turkey Companion Animal Pharmaceutical Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Saudi Arabia Companion Animal Pharmaceutical Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. UAE Companion Animal Pharmaceutical Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. Zoetis Revenue Growth Rate in Companion Animal Pharmaceutical Business (2016-2021)
Figure 62. Boehringer Ingelheim Revenue Growth Rate in Companion Animal Pharmaceutical Business (2016-2021)
Figure 63. Merck Animal Health Revenue Growth Rate in Companion Animal Pharmaceutical Business (2016-2021)
Figure 64. Elanco Animal Health Revenue Growth Rate in Companion Animal Pharmaceutical Business (2016-2021)
Figure 65. Bayer Animal Health Revenue Growth Rate in Companion Animal Pharmaceutical Business (2016-2021)
Figure 66. Virbac Revenue Growth Rate in Companion Animal Pharmaceutical Business (2016-2021)
Figure 67. Dechra Veterinary Products Revenue Growth Rate in Companion Animal Pharmaceutical Business (2016-2021)
Figure 68. Ceva Revenue Growth Rate in Companion Animal Pharmaceutical Business (2016-2021)
Figure 69. Vetoquinol Revenue Growth Rate in Companion Animal Pharmaceutical Business (2016-2021)
Figure 70. Meiji Revenue Growth Rate in Companion Animal Pharmaceutical Business (2016-2021)
Figure 71. Ouro Fino Saude Revenue Growth Rate in Companion Animal Pharmaceutical Business (2016-2021)
Figure 72. Parnell Revenue Growth Rate in Companion Animal Pharmaceutical Business (2016-2021)
Figure 73. Bottom-up and Top-down Approaches for This Report
Figure 74. Data Triangulation
Figure 75. Key Executives Interviewed
  • Global miRNA Microarray Kits & Reagents Market Insights and Forecast to 2028
    Published: 21-Jan-2022        Price: US 4900 Onwards        Pages: 109
    miRNA Microarray Kits & Reagents market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global miRNA Microarray Kits & Reagents market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028. Segment by Type - Microarray Wash Buffer Additive - miRNA Complete La......
  • Global Blood Plasma Derivatives Market Insights and Forecast to 2028
    Published: 21-Jan-2022        Price: US 4900 Onwards        Pages: 110
    Blood Plasma Derivatives market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Blood Plasma Derivatives market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028. Segment by Type - Albumin - Factor VIII - Factor IX - Immunoglobulin......
  • Global Metabolic Syndrome Market Insights and Forecast to 2028
    Published: 21-Jan-2022        Price: US 4900 Onwards        Pages: 118
    Metabolic Syndrome market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Metabolic Syndrome market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028. Segment by Type - Diabetes - Obesity - Hypercholesterolemia - Lysosomal storage dis......
  • Global Laboratory Biochemical Reagent Market Insights and Forecast to 2028
    Published: 21-Jan-2022        Price: US 4900 Onwards        Pages: 107
    Laboratory Biochemical Reagent market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Laboratory Biochemical Reagent market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028. Segment by Type - PCR Reagent Kits - Cell and Tissue Culture Reagents......
  • Global Infection Control Market Insights and Forecast to 2028
    Published: 21-Jan-2022        Price: US 4900 Onwards        Pages: 108
    Infection Control market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Infection Control market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028. Segment by Type - Disinfection Products - Sterilization Products and Services Segmen......
  • Global Metabolomics Market Insights and Forecast to 2028
    Published: 21-Jan-2022        Price: US 4900 Onwards        Pages: 114
    Metabolomics market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Metabolomics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028. Segment by Type - Separation Techniques - Detection Techniques - Others Segment by Appl......
  • Global American Ginseng Market Insights and Forecast to 2028
    Published: 21-Jan-2022        Price: US 4900 Onwards        Pages: 90
    American Ginseng market is segmented by Type and by Application. Players, stakeholders, and other participants in the global American Ginseng market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028. Segment by Type - Granular American Ginseng - capsule American Ginseng - Powder American Ginseng - Other......
  • Global Vitamin B5 (Calcium Pantothenate) Market Insights and Forecast to 2028
    Published: 21-Jan-2022        Price: US 4900 Onwards        Pages: 70
    Vitamin B5(Calcium Pantothenate) market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Vitamin B5(Calcium Pantothenate) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028. Segment by Type - Food Grade Vitamin B5 - Feed Grade Vitamin B5 - Pharmaceutical Grad......
  • Global Gadobutrol (CAS 138071-82-6) Market Insights and Forecast to 2028
    Published: 21-Jan-2022        Price: US 4900 Onwards        Pages: 94
    Gadobutrol (CAS 138071-82-6) market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Gadobutrol (CAS 138071-82-6) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028. Segment by Type - Single Dose Vials (2 mL, 7.5 mL, 10mL, and 15 mL) - Pharmacy Bulk Packages (30 mL ......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs